Related references
Note: Only part of the references are listed.Homozygosity for the transthyretin-Met30-gene in seven individuals with familial amyloidosis with polyneuropathy detected by restriction enzyme analysis of amplified genomic DNA sequences
Gōsta Holmgren et al.
CLINICAL GENETICS (2010)
Heart transplantation in a 68-year-old patient with senile systemic amyloidosis
U Fuchs et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Discordant penetrance of the trait for familial amyloidotic polyneuropathy in two pairs of monozygotic twins
G Holmgren et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families
V Plante-Bordeneuve et al.
JOURNAL OF MEDICAL GENETICS (2003)
Familial transthyretin-type amyloid polyneuropathy in Japan - Clinical and genetic heterogeneity
S Ikeda et al.
NEUROLOGY (2002)
Cure model analysis in cancer: an application to data from the Children's Cancer Group
R Sposto
STATISTICS IN MEDICINE (2002)
Transthyretin mutations in hyperthyroxinemia and amyloid diseases
MJM Saraiva
HUMAN MUTATION (2001)
Transthyretin related familial amyloid polyneuropathy
V Planté-Bordeneuve et al.
CURRENT OPINION IN NEUROLOGY (2000)
The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation
D Adams et al.
BRAIN (2000)
Advanced glycation end product in familial amyloidotic polyneuropathy (FAP)
N Nyhlin et al.
JOURNAL OF INTERNAL MEDICINE (2000)